Pediatric onset Crohn's colitis is characterized by genotype-dependent age-related susceptibility

Arie Levine1, Subra Kugathasan, Vito Annese

  • 1Pediatric Gastroenterology Unit, Wolfson Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. alevine@wolfson.health.gov.il

Inflammatory Bowel Diseases
|September 1, 2007
PubMed

Insights

Pediatric Crohn's disease (CD) location varies by age and NOD2/CARD15 gene mutations. Young children without these mutations show isolated colitis, while those with mutations have more ileocolitis.

Area of Science:

  • Gastroenterology
  • Genetics
  • Pediatric Medicine

Background:

  • Pediatric onset Crohn's disease (CD) presents differently than adult CD, with more colitis and less ileitis.
  • Age-related differences in disease location may indicate distinct genetic or host response factors.

Purpose of the Study:

  • To investigate the relationship between age of onset, NOD2/CARD15 mutations, and disease location in pediatric CD.
  • To identify specific phenotypes associated with genetic factors in early-onset CD.

Main Methods:

  • Analysis of 721 pediatric CD patients from three cohorts with high NOD2/CARD15 mutation frequency.
  • Exclusion of patients with isolated upper intestinal disease, focusing on 678 remaining patients.
  • Evaluation of interactions between age, NOD2/CARD15 status, and disease distribution (colitis, ileitis, ileocolitis).

Main Results:

  • An age-related tendency for isolated colitis was observed, particularly in younger children without NOD2/CARD15 mutations (P = 4.57 x 10(-5)).
  • Among pediatric CD patients with NOD2/CARD15 mutations, ileocolitis was more common under age 10, shifting to isolated ileitis over age 10 (P = 0.016).
  • NOD2/CARD15 mutations were not found to be associated with the age of disease onset.

Conclusions:

  • In early-onset pediatric CD, NOD2/CARD15 mutations are linked to a higher prevalence of ileocolitis and less isolated ileitis.
  • Isolated colonic disease in very young children without NOD2/CARD15 mutations suggests a specific genetic influence on early-onset CD phenotypes.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...